13F Data
13F filer · CIK 1343781

HealthCor Management, L.P.

NEW YORK, NY · filing since Q2 2013 · last filing Feb 15, 2023
Reported value
$109.1M
$-690.5M vs prior
Positions
22
New / sold out
6 / 43
Added / reduced
2 / 11
Turnover
4.1%
buys $18.7M · sells $737.6M
Top-10 weight
91.3%

Biggest buys vs Q3 2022

ChangeSecurityShares changeChange %Est. trade value
AddedDEXCOM INC+67,880+26.8%+$7.7M
NewACRIVON THERAPEUTICS INC+284,201–+$3.3M
NewCONMED CORP+27,500–+$2.4M
NewINTUITIVE SURGICAL INC+5,750–+$1.5M
NewPENUMBRA INC+5,000–+$1.1M
NewRAIN ONCOLOGY INC+120,000–+$960.0K
AddedHYPERFINE INC+1,131,500+41.2%+$950.5K
NewSILK RD MED INC+15,000–+$792.8K

Biggest sells vs Q3 2022

ChangeSecurityShares changeChange %Est. trade value
Sold outABBVIE INC-310,250-100.0%$-41.6M
Sold outAGILENT TECHNOLOGIES INC-338,030-100.0%$-41.1M
ReducedBIOMARIN PHARMACEUTICAL INC-391,273-51.5%$-40.5M
Sold outBOSTON SCIENTIFIC CORP-958,600-100.0%$-37.1M
Sold outLLYLILLY ELI & CO-103,150-100.0%$-33.4M
Sold outAMERISOURCEBERGEN CORP-239,150-100.0%$-32.4M
Sold outUNITEDHEALTH GROUP INC-62,980-100.0%$-31.8M
Sold outDANAHER CORPORATION-117,800-100.0%$-30.4M
Sold outTENET HEALTHCARE CORP-518,990-100.0%$-26.8M
Sold outTHERMO FISHER SCIENTIFIC INC-51,240-100.0%$-26.0M
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $1.7BQ3 2013: $1.9BQ4 2013: $1.6BQ1 2014: $1.7BQ2 2014: $2.0BQ3 2014: $1.9BQ4 2014: $1.8BQ1 2015: $2.1BQ2 2015: $2.0BQ3 2015: $1.8BQ4 2015: $1.6BQ1 2016: $1.8BQ2 2016: $1.8BQ3 2016: $1.6BQ4 2016: $1.8BQ1 2017: $2.2BQ2 2017: $2.8BQ3 2017: $3.0BQ4 2017: $3.1BQ1 2018: $2.9BQ2 2018: $3.1BQ3 2018: $3.0BQ4 2018: $3.2BQ1 2019: $2.5BQ2 2019: $2.6BQ3 2019: $2.6BQ4 2019: $2.8BQ1 2020: $2.3BQ2 2020: $2.4BQ3 2020: $2.5BQ4 2020: $2.6BQ1 2021: $2.8BQ2 2021: $2.5BQ3 2021: $2.3BQ4 2021: $1.8BQ1 2022: $1.5BQ2 2022: $995.1MQ3 2022: $799.6MQ4 2022: $109.1M
Q2 2013Q4 2022

Holdings · Q4 2022

#SecuritySharesValueWeight
1BIOMARIN PHARMACEUTICAL INCCOM367,765$38.1M34.88%
2DEXCOM INCCOM321,380$36.4M33.35%
3CYTOKINETICS INCCOM NEW164,440$7.5M6.91%
4ACRIVON THERAPEUTICS INCCOMMON STOCK284,201$3.3M3.00%
5HYPERFINE INCCOM CL A3,880,900$3.3M2.99%
6ALKERMES PLCSHS110,000$2.9M2.63%
7CONMED CORPCOM27,500$2.4M2.23%
8NEUROCRINE BIOSCIENCES INCCOM20,000$2.4M2.19%
9SYNDAX PHARMACEUTICALS INCCOM70,000$1.8M1.63%
10CHINOOK THERAPEUTICS INCCOM60,000$1.6M1.44%
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.